Michael A. DesJardin

Insider Reports History

Location
Palo Alto, CA
Signature
/s/ Patrick McIlvenny, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael A. DesJardin:

Company Role Class Num Shares Value Price $ Report Date Ownership
Horizon Therapeutics Public Ltd Co EVP, Technical Operations Restricted Stock Units (RSUs) 14,283 05 Jan 2023 Direct
Horizon Therapeutics Public Ltd Co EVP, Technical Operations Performance Restricted Stock Units (PSUs) 5,236 05 Jan 2023 Direct
Horizon Therapeutics Public Ltd Co EVP, Technical Operations Ordinary Shares 0 $116.50 06 Oct 2023 Direct
Horizon Therapeutics Public Ltd Co EVP, Technical Operations Performance Restricted Stock Units 0 06 Oct 2023 Direct
Horizon Therapeutics Public Ltd Co EVP, Technical Operations Restricted Stock Units 0 06 Oct 2023 Direct
Horizon Therapeutics Public Ltd Co EVP, Technical Operations Stock Option (Right to Buy) 0 02 Mar 2023 Direct

Insider Reports Filed by Michael A. DesJardin

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000120919123052360-desjardin-michael-a-2023-10-06 Horizon Therapeutics Public Ltd Co 06 Oct 2023 13 -$14,776,627 4 EVP, Technical Operations 06 Oct 2023, 17:54
/report/000120919123016340-desjardin-michael-a-2023-03-02 Horizon Therapeutics Public Ltd Co 02 Mar 2023 4 +$66,953 4 EVP, Technical Operations 06 Mar 2023, 15:48
/report/000120919123002437-desjardin-michael-a-2023-01-04 Horizon Therapeutics Public Ltd Co 04 Jan 2023 10 -$3,046,269 4 EVP, Technical Operations 06 Jan 2023, 16:52
/report/000120919123000935-desjardin-michael-a-2023-01-01 Horizon Therapeutics Public Ltd Co 01 Jan 2023 3 -$1,088,042 4 EVP, Technical Operations 04 Jan 2023, 15:25
/report/000120919122062914-desjardin-michael-a-2022-12-27 Horizon Therapeutics Public Ltd Co 27 Dec 2022 3 $0 4 EVP, Technical Operations 29 Dec 2022, 15:26
/report/000120919122024440-desjardin-michael-a-2022-04-12 Horizon Therapeutics Public Ltd Co 12 Apr 2022 2 -$2,286,703 4 EVP, Technical Operations 14 Apr 2022, 16:49
/report/000120919122016227-desjardin-michael-a-2022-03-02 Horizon Therapeutics Public Ltd Co 02 Mar 2022 2 -$3,401,752 4 EVP, Technical Operations 04 Mar 2022, 15:19
/report/000120919122004634-desjardin-michael-a-2022-01-21 Horizon Therapeutics Public Ltd Co 21 Jan 2022 3 -$157,716 4 EVP, Technical Operations 24 Jan 2022, 16:07
/report/000120919122002293-desjardin-michael-a-2022-01-04 Horizon Therapeutics Public Ltd Co 04 Jan 2022 9 -$4,203,548 4 EVP, Technical Operations 06 Jan 2022, 19:59
/report/000120919121048787-desjardin-michael-a-2021-07-28 Horizon Therapeutics Public Ltd Co 28 Jul 2021 3 -$368,898 4 EVP, Technical Operations 30 Jul 2021, 16:24